TrialBritish journal of clinical pharmacology2019

The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.

Antonia M Joussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.